The aim of our 2017/2018 breeding programme is to develop a variety of germplasms with special features for cultivation of medicinal cannabis.
A major goal of our work is developing hybrid germplasms for cultivation.
We seek specific genetic traits that facilitate cutting edge farming techniques and efficient recovery of high-quality cannabinoids.
In order to repeatedly develop new varieties with new or improved properties, our research staff must have access to a variety of different genes, gene variants, characteristics, plant lines, varieties or wild species. The broadest possible genetic variability within a given crop is crucial for breeding.
Our research is conducted largely in vitro, i.e., in test tubes. In vitro research involves studying organisms under artificial experimental conditions. Biological experiments can be monitored better in vitro than in vivo. For example, conditions can be more easily adjusted in the laboratory, and parameters can be modified individually. The findings reached through in vitro research are then carefully verified by means of a series of in vivo experiments before the new germplasm is marketed and released for use in commercial cultivation.
Whether they are conducted in the conventional manner or using new procedures, the core objectives of all plant breeding are always the same: to increase the crop’s yield and its resistance to plant diseases and pests, to adapt it to external conditions such as climate and soil, to make it easier to cultivate and, crucially for plants grown for medicinal purposes, to improve the quality of the harvest.